Conference - The future of ARVs in Africa


WELCOME

We are delighted to invite you to join us for the 2nd Southern African HIV Clinicians Society (SAHCS) long-acting treatment and prevention conference entitled ‘The future of antiretrovirals in Africa: Long-acting agents and beyond’.

The conference will focus on long-acting treatment and prevention, with programme sessions including outcomes of implementation studies, prevention studies, and treatment studies. 
The event will provide healthcare professionals with up-to-date clinical knowledge and clinical skills development around patient treatment, care and support.
 

CONFERENCE CO-CHAIRS

Professor Catherine Orrell
MBChB MMed MSc (Clin Pharmacol) PhD (Cape Town)
Professor Catherine Orrell is an HIV Clinician and Clinical Pharmacologist. She has been PI on more than 20 antiretroviral clinical trials since 2004: including a range of efficacy, toxicity, interaction and dosing studies. She conducts research at the University of Cape Town; and in community settings / primary healthcare clinic environments, leading a clinical research site in Gugulethu. The site is currently conducting clinical trials of novel methods to monitor and improve ART adherence and explore impact on HIV-1 resistance; as well as exploring the use of long-acting antiretroviral therapy in under-served populations.



Dr Nosisa Sipambo
MBBCh (Wits) MMed (Paeds) Wits; FCPaed (SA); Cert ID (SA) Paed
Dr Nosisa Sipambo is a paediatric infectious diseases specialist. She is the head of Harriet Shezi Children’s Clinic (HSCC) and head of the paediatric infectious diseases unit at Chris Hani Baragwanath Academic Hospital. HSCC has one of the largest cohorts of children and adolescents living with HIV (CALHIV), over 11 000 to date. HSCC is a referral site for surrounding clinics and hospitals for advanced HIV disease and infectious diseases cases. She is passionate about developing and implementing quality improvement projects that improve health care services and quality of life for CALHIV. Her research interests include perinatal HIV infection, adolescent health and virologic failure in children living with HIV.


GENERAL INFORMATION

Conference date: Tuesday, 29 October 2024
Conference venue: Maslow Hotel, corner of Rivonia Road and Grayston Drive, Sandton, Johannesburg, South Africa.


CONFERENCE PROGRAMME

Join us for a full day filled with brilliant presentations from top HIV-experts!

We will be discussing what is on the horizon with new drugs for HIV, focusing on long-acting treatment and prevention, reviewing the latest research from studies such as PURPOSE-1, CARES, IMPALA, CAPELLA, CALIBRATE, AFINaty, amongst others, and engaging in stimulating discussions around guidelines and readiness for implementation.

This programme has been accredited with 7 Clinical CPD points.

View the programme - Click here


REGISTRATION 

Registration form - Click here
The registration fee is R800 per person. Refreshments, lunch and parking are included.

To make payment for your conference registration please follow this Payfast link:
      

  

SPONSORSHIP

Should you wish to participate as a sponsor or exhibitor please contact the SAHCS Secretariat on janice@sahivcs.org for assistance.


CONTACT

For more information, please contact Janice Candlish: 
  • Telephone +27 (0) 11 728 7365  
  • Email janice@sahivcs.org  


Support for the 2nd SAHCS long-acting treatment and prevention conference has been provided by the following:




 


Previous conference information:

The 1st SAHCS long-acting treatment and prevention conference, hosted on 20 September 2022 at Indaba Hotel in Fourways, was filled with brilliant presentations from top HIV-experts with a highly engaged audience and powerful discussions - there may be barriers but if we all come together and deliver scientific solutions through a person-centered approach alongside statutory support we can curb this HIV epidemic!

20 September 2022 - Conference programme – download here
Conference presentations: